Stock Updates

Is Novo Nordisk A/S(NYSE: NVO), a large market cap stock a smart buy?

With a market cap of has a large market cap size. Novo Nordisk A/S (NYSE: NVO) has been on the stock market since its IPO date on the 1/4/1982. Novo Nordisk A/S is in the Drug Manufacturers – Other industry and Healthcare sector. Average volume for Novo Nordisk A/S, is 2230, and so far today it has a volume of 4475200. Performance year to date since the 1/4/1982 is -18.72%.

To help you determine whether Novo Nordisk A/S is undervalued the following values will help you decide. P/E is 21.61 and forward P/E is 18.89. PEG perhaps more useful shows that Novo Nordisk A/S has a value for PEG of 2.04. P/S ratio is 5.61 and the P/B ratio is 18.16. The P/Cash and P/Free cash flow is 40.64 and 30.04 respectively.

At the current price Novo Nordisk A/S is trading at, 45.95 (0.13% today), Novo Nordisk A/S has a dividend yield of 3.07%, and this is covered by a payout ratio of 45.20%. Earnings per share (EPS) is 2.13, and this is looking to grow in the next year to 6.76% after growing 34.30% this past year. EPS growth quarter over quarter is 21.50%, and 1.50% for sales growth quarter over quarter.

The number of shares outstanding is 2025.8, and the number of shares float is 1356.68. The senior management bring insider ownership to 26.40%, and institutional ownership is at 10.00%. The float short is 0.15%, with the short ratio at a value of 0.91. Management has seen a return on assets of 41.50%, and also a return on investment of 85.00%.

The ability for Novo Nordisk A/S, to deal with debt, means it current ratio is 1.3, and quick ratio is 0.9. Long term debt/equity is 0 and total debt/equity is 0.01. In terms of margins, Novo Nordisk A/S has a gross margin of 84.80%, with its operating margin at 43.40%, and Novo Nordisk A/S has a profit margin of 32.70%.

The 52 week high is -19.98%, with 2.25% being its 52 week low. The 20 day simple moving average is -9.98% and the 200 day simple moving average is -13.29%.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Tony Dabbs

Leave a Comment